NFKB1 and inflammatory bowel disease: Therefore, the NF-κB pathway is considered to be a critical mediator of IBD pathology (NEURATH et al. 1998; Mitsuyama et al. 2001; Peng et al. 2020; Chawla et al. 2021; Sousa et al. 2022).